Contact
searchSearch
HMP Global

Biosimilars Topic Center

Featured Article

Conference Coverage
Real-World Strategies for Implementing Biosimilars
04/12/2023
Hannah Musick
Speakers at AMCP 2023 discussed the current landscape of biosimilars from a payer perspective as well as lessons learned from health system biosimilar adoption. 
Speakers at AMCP 2023 discussed the current landscape of biosimilars from a payer perspective as well as lessons learned from health system biosimilar adoption. 
Speakers at AMCP 2023 discussed...
04/12/2023
First Report Managed Care
From First Report Managed Care
Conference Insider
Addressing and Understanding Challenges Linked With Adopting Biosimilars Into Practice
12/08/2020
In a session at ASHP Midyear 2020, Osama Abdelghany, PharmD, MHA, BCOP Yale New Haven Hospital, and David L Crosby, PharmD, BCOP, BCPS, Dartmouth-Hitchcock Health, provide a variety of clinical, operational, and payer coverage considerations...
In a session at ASHP Midyear 2020, Osama Abdelghany, PharmD, MHA, BCOP Yale New Haven Hospital, and David L Crosby, PharmD, BCOP, BCPS, Dartmouth-Hitchcock Health, provide a variety of clinical, operational, and payer coverage considerations...
In a session at ASHP Midyear...
12/08/2020
Pharmacy Learning Network
Quiz
Identifying Pharmacist Knowledge of a Medication Drug Type
11/24/2020
Based on recent data, pharmacists are more well-informed about which medication type—with more than 80% demonstrating solid knowledge of their safety, efficacy, compatibility, and costs?
Based on recent data, pharmacists are more well-informed about which medication type—with more than 80% demonstrating solid knowledge of their safety, efficacy, compatibility, and costs?
Based on recent data,...
11/24/2020
Pharmacy Learning Network
News
Most Pharmacists Show Good Grasp of Biosimilar Medications, Study Finds
11/20/2020
“Pharmacists, being the drug experts, need to be well aware of the applied handling of biosimilar medicines,” researchers wrote. “They are an integral educator, trailblazer, and advocate of biosimilar integration across all clinical settings.”
“Pharmacists, being the drug experts, need to be well aware of the applied handling of biosimilar medicines,” researchers wrote. “They are an integral educator, trailblazer, and advocate of biosimilar integration across all clinical settings.”
“Pharmacists, being the drug...
11/20/2020
Pharmacy Learning Network
Newsfeed
Biosimilar Infliximab Appears Effective in Crohn`s Disease
12/11/2018
An infliximab biosimilar appears to be safe and effective in infliximab-naive patients with Crohn's disease, according to a recent study.
An infliximab biosimilar appears to be safe and effective in infliximab-naive patients with Crohn's disease, according to a recent study.
An infliximab biosimilar appears...
12/11/2018
Pharmacy Learning Network
News
Etanercept Biosimilar is Effective, Well-Tolerated for Rheumatoid Arthritis
02/16/2018
A recent study examined the efficacy of a biosimilar for treating patients with rheumatoid arthritis who respond inadequately to methotrexate
A recent study examined the efficacy of a biosimilar for treating patients with rheumatoid arthritis who respond inadequately to methotrexate
A recent study examined the...
02/16/2018
Pharmacy Learning Network
News
Biosimilar Infliximab Appears Safe, Effective in IBD Patients
12/15/2017
Researchers examined the effectiveness of switching to a biosimilar version of a drug in patients with IBD. 
Researchers examined the effectiveness of switching to a biosimilar version of a drug in patients with IBD. 
Researchers examined the...
12/15/2017
Pharmacy Learning Network
News
Pharmacist Role in Promoting Proper Biosimilar Usage
12/14/2017
Evelyn Hermes-Desantis, PharmD, BCPS, recently discussed the many factors involved in managing biosimilars in the hospital setting and the role pharmacists play in promoting their appropriate use in the context of safe patient care.
Evelyn Hermes-Desantis, PharmD, BCPS, recently discussed the many factors involved in managing biosimilars in the hospital setting and the role pharmacists play in promoting their appropriate use in the context of safe patient care.
Evelyn Hermes-Desantis, PharmD,...
12/14/2017
Pharmacy Learning Network
News
FDA Approves Another Biosimilar for RA Drug
12/14/2017
The FDA has approved a biosimilar for multiple autoimmune diseases. 
The FDA has approved a biosimilar for multiple autoimmune diseases. 
The FDA has approved a...
12/14/2017
Pharmacy Learning Network
News
FDA Approves First Biosimilar for Breast, Stomach Cancer
12/01/2017
The FDA has approved a biosimilar for two types of cancer.
The FDA has approved a biosimilar for two types of cancer.
The FDA has approved a...
12/01/2017
Pharmacy Learning Network
News
The Challenges of Bringing Biosimilars to Market
11/21/2017
Edward Li, Pharm D, MPH, BCOP, a professor in the Department of Pharmacy Practice at the University of New England College of Pharmacy, explains how industry experts can help bring biosimilars to the market faster.
Edward Li, Pharm D, MPH, BCOP, a professor in the Department of Pharmacy Practice at the University of New England College of Pharmacy, explains how industry experts can help bring biosimilars to the market faster.
Edward Li, Pharm D, MPH, BCOP, a...
11/21/2017
Pharmacy Learning Network

Newsfeed

News
Communication Needed to Improve Biosimilar Transition, Adherence
10/19/2017
Patients with rheumatoid arthritis, psoriatic arthritis, or ankylosing spondylitis who switched from an originator treatment to a biosimilar stopped taking the biosimilar medication within 6 months, a study showed. 
Patients with rheumatoid arthritis, psoriatic arthritis, or ankylosing spondylitis who switched from an originator treatment to a biosimilar stopped taking the biosimilar medication within 6 months, a study showed. 
Patients with rheumatoid...
10/19/2017
Pharmacy Learning Network
News
FDA Approves Amgen`s Cheaper Copy of Arthritis Drug Humira
09/23/2016
The FDA has approved a cheaper, biosimilar version of AbbVie's top-selling arthritis drug, Humira.
The FDA has approved a cheaper, biosimilar version of AbbVie's top-selling arthritis drug, Humira.
The FDA has approved a cheaper,...
09/23/2016
Pharmacy Learning Network
News
Novartis Biosimilar Takes Aim at Amgen`s Enbrel
10/23/2015
The FDA has accepted Novartis unit Sandoz's regulatory submission for approval of a biosimilar copy of Amgen's blockbuster anti-TNF drug Enbrel, the Swiss drugmaker said.
The FDA has accepted Novartis unit Sandoz's regulatory submission for approval of a biosimilar copy of Amgen's blockbuster anti-TNF drug Enbrel, the Swiss drugmaker said.
The FDA has accepted Novartis...
10/23/2015
Pharmacy Learning Network
News
FDA Proposes Adding Suffixes to Distinguish Biosimilar Drug Names
08/28/2015
The FDA proposed on Thursday identifying cheaper versions of biologic drugs with a suffix to distinguish them from their more expensive, branded counterparts.
The FDA proposed on Thursday identifying cheaper versions of biologic drugs with a suffix to distinguish them from their more expensive, branded counterparts.
The FDA proposed on Thursday...
08/28/2015
Pharmacy Learning Network
News
Bottles of Children’s Ibuprofen Recalled Nationwide Over Contamination Concerns
03/19/2026
Grace Taylor, MS, MA
A nationwide recall of children’s ibuprofen oral suspension has been initiated after reports of foreign material, including gel-like masses and black particles, were found in affected bottles.
A nationwide recall of children’s ibuprofen oral suspension has been initiated after reports of foreign material, including gel-like masses and black particles, were found in affected bottles.
A nationwide recall of...
03/19/2026
Pharmacy Learning Network
News
Apotex Recalls Brimonidine/Timolol Ophthalmic Solution Over Sterility Concerns
03/19/2026
Grace Taylor, MS, MA
Apotex has voluntarily recalled over 100 000 vials of brimonidine/timolol ophthalmic solution distributed nationwide due to concerns about lack of sterility.
Apotex has voluntarily recalled over 100 000 vials of brimonidine/timolol ophthalmic solution distributed nationwide due to concerns about lack of sterility.
Apotex has voluntarily recalled...
03/19/2026
Pharmacy Learning Network
PharmLaw
Wholesale Pharmaceutical Executives Sentenced in $92 Million Drug Diversion Scheme
03/18/2026
Grace Taylor, MS, MA
Two wholesale pharmaceutical executives were sentenced in a large-scale drug diversion case that raised concerns about medication safety and supply chain integrity.
Two wholesale pharmaceutical executives were sentenced in a large-scale drug diversion case that raised concerns about medication safety and supply chain integrity.
Two wholesale pharmaceutical...
03/18/2026
Pharmacy Learning Network
News
Midodrine Hydrochloride Under Class II Recall Due to Inadequately Sealed Blister Packaging
03/12/2026
Hannah Musick
The Harvard Drug Group LLC is recalling one lot of midodrine hydrochloride tablets nationwide due to inadequately sealed blister packaging that may compromise product integrity.
The Harvard Drug Group LLC is recalling one lot of midodrine hydrochloride tablets nationwide due to inadequately sealed blister packaging that may compromise product integrity.
The Harvard Drug Group LLC is...
03/12/2026
Pharmacy Learning Network
News
Teva Metoprolol Succinate Tablets Recalled for Failed Dissolution Specifications
03/12/2026
Hannah Musick
The US Food and Drug Administration (FDA) has issued a Class II recall for multiple strengths of Teva’s metoprolol succinate extended-release tablets due to failed dissolution specifications, potentially affecting consistent cardiovascular...
The US Food and Drug Administration (FDA) has issued a Class II recall for multiple strengths of Teva’s metoprolol succinate extended-release tablets due to failed dissolution specifications, potentially affecting consistent cardiovascular...
The US Food and Drug...
03/12/2026
Pharmacy Learning Network
News
Cipla Nilotinib Capsules Recalled for Stability Specification Failures
03/12/2026
Hannah Musick
The US Food and Drug Administration (FDA) has issued a Class III recall for select lots of Cipla’s nilotinib capsules after stability testing identified out-of-specification appearance and description results.
The US Food and Drug Administration (FDA) has issued a Class III recall for select lots of Cipla’s nilotinib capsules after stability testing identified out-of-specification appearance and description results.
The US Food and Drug...
03/12/2026
Pharmacy Learning Network
PharmLaw
Novo Nordisk Drops Patent Suit as Hims & Hers Shifts to FDA-Approved Semaglutide Products
03/11/2026
Hannah Musick
Novo Nordisk has dropped its patent lawsuit against Hims & Hers after the telehealth company agreed to stop promoting compounded GLP-1 products and instead offer US Food and Drug Administration (FDA)-approved Ozempic and Wegovy at established...
Novo Nordisk has dropped its patent lawsuit against Hims & Hers after the telehealth company agreed to stop promoting compounded GLP-1 products and instead offer US Food and Drug Administration (FDA)-approved Ozempic and Wegovy at established...
Novo Nordisk has dropped its...
03/11/2026
Pharmacy Learning Network
News
Rising Pharma Recalls Lot of Temozolomide Capsules Following Impurities Concern
03/05/2026
Grace Taylor, MS, MA
Rising Pharma has voluntarily recalled one nationwide lot of temozolomide 5 mg capsules after stability testing revealed out-of-specification impurities results.
Rising Pharma has voluntarily recalled one nationwide lot of temozolomide 5 mg capsules after stability testing revealed out-of-specification impurities results.
Rising Pharma has voluntarily...
03/05/2026
Pharmacy Learning Network
News
Lidocaine/Racepinephrine Spray Recalled Over Expiration Date Issues
03/05/2026
Grace Taylor, MS, MA
HTO Nevada has voluntarily recalled more than 27 000 bottles of Five-Star Vasocaine Spray nationwide after determining that stability data do not support the product’s labeled expiration dates.
HTO Nevada has voluntarily recalled more than 27 000 bottles of Five-Star Vasocaine Spray nationwide after determining that stability data do not support the product’s labeled expiration dates.
HTO Nevada has voluntarily...
03/05/2026
Pharmacy Learning Network
News
Nationwide Recall of Isotretinoin Capsules Issued Over Dissolution Failure
03/05/2026
Grace Taylor, MS, MA
Mylan Pharmaceuticals has voluntarily recalled select lots of isotretinoin 40 mg capsules distributed nationwide after the product failed to meet dissolution specifications.
Mylan Pharmaceuticals has voluntarily recalled select lots of isotretinoin 40 mg capsules distributed nationwide after the product failed to meet dissolution specifications.
Mylan Pharmaceuticals has...
03/05/2026
Pharmacy Learning Network

Insights

Interactive Features

Subscribe Today

Pharmacy Learning Network Newsletter

HMP Global Products

Events

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2026 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Terms of Use